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Abstract: Our understanding of the tuberculosis (TB) epidemic in children is incomplete 
due to challenges in diagnosis and reporting. Children have also been largely excluded from 
research and advocacy. However, the tide appears to be turning and interest in pediatric TB is 
 increasing. In this article, we explore the epidemiology of childhood TB by first reviewing the 
natural history of TB in children and the factors that impact on each of the stages from exposure 
to disease. We then discuss how these factors affect what we see at a country and regional level. 
Finally, we assess the burden of childhood TB globally.
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Introduction
Children with tuberculosis (TB) have historically been neglected by clinicians, policy 
makers, academics, and advocates. In part, this has been due to the perception that 
children are rarely infectious, and consequently contribute little to the propagation 
of the epidemic; in part, because of the perception that they rarely develop severe 
disease; and in part, because in many countries, child health generally has not been 
important or prioritized.1 The World Health Organization (WHO) policy of targeting 
sputum smear-positive cases of TB for epidemic control, the directly observed treat-
ment short-course (DOTS) strategy, largely ignores children, who rarely have sputum 
smear-positive TB.2
However, children with TB are important. Not only is there a clinical imperative 
to identify, diagnose, and treat children for a disease that is curable, but by ignoring 
childhood TB, efforts at epidemic TB control will ultimately fail. This is because 
children provide the reservoir out of which future cases will develop. Without the 
successful detection and treatment of TB infection and disease in children, elimination 
strategies will be ineffective.
Over the last few years, however, interest in childhood TB has increased dramatically. 
For the first time ever, in 2012, the WHO included an estimate for childhood TB in their 
annual report3 and in 2012, the focus of World TB Day was children.4 The TB Alliance, 
in 2013, was awarded up to $16.7 million from UNITAID to develop child-friendly 
formulations for TB drugs for children5 and in 2013, the childhood TB roadmap was 
launched with a clear vision of what would be required to eliminate childhood TB.6
Epidemiology
When considering the epidemiology of childhood TB, it is important to consider 
which children develop TB, when they develop TB, where they develop TB, and why. 
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Understanding the epidemiology helps clinicians make an 
assessment of the probability that the child in front of him/
her has TB. It also determines the pre-test probability of TB 
prior to investigation, thereby influencing the interpretation 
of these tests. On a programmatic level, it is important for 
policy makers and public health workers to design services 
and allocate resources. Finally, only by understanding the 
epidemiology and burden can we advocate appropriately 
for children with TB.
In considering the epidemiology of childhood TB, a 
number of stages will be discussed. First, we will discuss the 
natural history of TB in children and the factors that influence 
it. Second, we will explore how this translates into the varying 
epidemics that are seen in different countries. Finally, we will 
assess what this means in terms of the overall burden.
Natural history
For a child to develop TB, they must first be exposed to an 
infectious case of pulmonary TB, usually, but not always, 
from an adult. The Mycobacterium tuberculosis bacilli must 
reach the terminal alveoli and then overcome the innate 
immune system. Once the child is sensitized to the TB 
antigen and produces a positive test of infection (either a 
tuberculin skin test [TST] or an interferon-gamma release 
assay [IGRA]), they are said to have TB infection. At some 
point in the future, the bacilli will overcome the immune 
system and multiply in number. When the child develops 
the symptoms and signs of illness they are said to have TB 
disease. Certain risk factors determine the risk of exposure, 
and further factors then determine the risk of progression 
from exposure to infection and from infection to disease 
(Figure 1). These will be discussed in turn. The relation-
ship between TB and poverty is compelling and confounds 
almost every other risk factor.7 Not only is poverty associ-
ated with increased risk of a child being exposed to TB, it 
also influences the risk of becoming infected and also of 
then developing disease.
Exposure to tuberculosis
Probably the greatest influence on the risk of TB exposure for 
a child is the background prevalence of TB in a  community. 
The child has far higher risk of TB exposure in high TB 
prevalence regions. It is important to note, however, that 
TB prevalence is very heterogeneous in many countries, 
with different epidemics frequently existing alongside each 
other.8,9 This will be discussed later. Population density will 
also influence the risk of a child coming into contact with 
an infectious TB case, as more dense populations lead to 
more human encounters and encounters of more intense and 
prolonged physical proximity.
The age of the child will influence their risk of TB 
exposure, as older children interact with more adults in their 
day-to-day life. They can therefore be exposed to infectious 
cases of TB at home or in the community. Younger, especially 
pre-school, children interact with fewer adults, and gener-
ally come into contact with adults only in their family units. 
This will reduce their chances of being exposed to an adult 
with infectious TB. In addition to the age of the child, the 
household composition, the physical structure of the house, 
and the sleeping practices of the society will influence the 
risk of exposure. On an individual basis, the human density 
within a house will impact on the risk of exposure to a TB 
source case. Children living in houses with multiple adults 
are more likely to come into contact with an infectious case. 
In some societies, children sleep together in one room with 
adults in another, while in other communities, core family 
units sleep in the same room.
The weather in a community can influence exposure in 
a number of ways. Temperature and rainfall can influence 
how much time children spend outside in relative safety 
and how much time they spend indoors potentially exposed. 
 Window opening will directly impact on ventilation10 and 
is in turn influenced by temperature. Wind speed can also 
impact on ventilation both outside and through windows.11 
Sunlight will determine vitamin D levels among children, 
which will be discussed later when considering the risk 
of infection and disease progression. Seasonal peaks in 
 childhood TB have been described in different communities 
and likely reflect a mixture of environment-related exposure 
factors combined with vitamin D levels.12–17
How a child lives will influence their risk of exposure to 
a TB source case. If children are taken on public transport 
systems, taken to sporting, family, or religious gatherings, or 
if children attend such activities on their own, they are likely 
to be at increased risk of exposure to TB. The cultural prac-
tices surrounding childcare and school within a community 
can also have a direct impact on TB exposure.18 Class size 
in school, ventilation, and mixed age classes can also affect 
the risk of exposure.
The issues of human immunodeficiency virus (HIV) and 
alcohol may impact on TB exposure, as both epidemics have 
an intimate and complex relationship with TB. HIV-infected 
adults are at significantly increased risk of TB disease.19,20 
Children living with HIV-infected adults are likely to be 
at an increased risk of being HIV-infected themselves, and 
are therefore at an increased risk of being exposed to TB. 
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Those who abuse alcohol are more likely to be exposed to 
TB due to behavioral practices and by attending places that 
are more likely to have other TB source cases. They are more 
likely to develop TB due to impaired immunity, are less 
likely to seek care, and also are less likely to have successful 
treatment.21 All of these factors lead to increased risk of TB 
exposure for children living in alcohol-affected households.
M. tuberculosis infection
Following exposure, the risk that a child will develop 
M. tuberculosis infection will be influenced by the 
 infectiousness of the source case, the duration of the interac-
tion, the intensity of the interaction, the infectiousness of the 
organism, and the immunology of the child.22,23
Source cases are more infectious if they are sputum smear-
positive compared to sputum smear-negative,24,25 and although 
HIV-infected TB cases are considered poor producers of spu-
tum, the evidence that they are less infectious is mixed.26–29 
The bacterial load in the sputum influences infectivity.  Sputum 
is graded using a logarithmic scale with one plus (+) contain-
ing 1–99 bacilli per 100 fields, two pluses (++) 1–10 bacilli 
per field, and three pluses (+++) .10 bacilli per field. 
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Figure 1 Risk factors for tuberculosis exposure, infection and disease in children.
Abbreviations: BCG, Bacillus Calmette–Guérin; HIV, human immunodeficiency virus; TB, tuberculosis.
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Higher bacterial loads are  associated with increased risk 
of transmission.24,30 In addition, more extensive pulmonary 
disease, defined as affecting multiple zones on a chest radio-
graph, is associated with increased risk of TST positivity in 
the contact, independent of mycobacterial load.24,31,32 The 
duration of cough has been shown to affect transmission, with 
children more likely to be infected if the source case has been 
coughing for a longer period of time.32,33
First-degree relatives are more likely to transmit myco-
bacteria that result in child contacts becoming infected than 
more distant relatives, and children sleeping in the same 
room as source cases are more likely to have a positive TST 
than those sleeping in different rooms.31,32,34–36 The physical 
proximity of how close a child sleeps to a source case influ-
ences transmission,22,31,32 but general markers of crowding 
are also associated with risk of childhood infection.22 The 
influence of solid fuel smoke and cigarette smoke is complex 
but children are more likely to become infected if someone 
in the house smokes cigarettes or if solid fuels are used to 
cook or for heating.22,25,37–39 This may be a result of impaired 
mucosal integrity, mucosal immunity, or inhibition of mac-
rophage or T cell function.40,41
The evidence around whether certain mycobacterial 
strains are more infectious is similarly confusing. There is 
some evidence to suggest that the Beijing strain is more likely 
to transmit and cause disease than other strains.42 However, 
other studies have failed to demonstrate this relationship.43,44 
Some studies suggest that Bacillus Calmette–Guérin (BCG) 
vaccination provides less protection from Beijing as opposed 
to other strains,45 and there appears to be a strong relation-
ship between Beijing and drug resistance.40,41 Whilst older 
studies in guinea pigs suggested that isoniazid-resistant 
strains were less infectious,46 more recent studies in human 
populations have not shown drug-resistant strains to be less 
infectious.47–51
Most contact studies demonstrate that as children become 
older they are more likely to have a positive test of infec-
tion.32,52,53 As these tests reflect infection at any time in their 
life, these results are not surprising, as older children are more 
likely to have been exposed to infectious cases of TB in the 
community in addition to the identified source case. Whether 
uninfected older children are more likely than uninfected 
younger children to develop a positive infection test following 
known exposure is unclear. Outbreak investigations in low 
prevalence settings suggest that perhaps younger children 
are more vulnerable, but this may be explained by increased 
intensity of exposure.54 Although BCG has well- established 
efficacy against the progression from TB infection to severe 
forms of disease, there is emerging evidence that it may also 
protect against the establishment of infection.55–58 Many of 
these studies have employed IGRAs to detect TB infection 
following exposure, as it is not confounded by BCG and so 
this effect has only recently been possible to fully explore. 
Another issue that can impact on the risk of infection fol-
lowing exposure is parasitic infections. Studies have dem-
onstrated that helminth infections can either increase59 or 
reduce60 the risk of TST positivity following exposure to an 
infectious source case, and other studies tentatively suggest 
that protozoa infections may protect against TB infection.59,61 
Finally, our understanding of genetic susceptibility to TB has 
improved dramatically since the development of genome-
wide association studies. These suggest that certain genes 
may play an important role in determining susceptibility,62,63 
particularly vitamin D receptor polymorphisms.64
Tuberculosis disease
From studies that examined the natural history of TB, 
conducted prior to the chemotherapy era, we know that 
following infection, age plays one of the most significant 
roles in determining which children will progress to disease. 
Infected infants (those less than 12 months of age) have a 
50% risk of progression to disease. Children from 1–2 years 
have a 20%–30% risk, those from 3–5 years a risk of 5%, 
those 5–10 years old only a 2% risk and older children an 
adult-like risk (5%).65–67 Young children are also more likely 
to develop the most severe forms of TB, such as TB menin-
gitis or military TB. HIV also plays a significant role. In the 
absence of anti-retroviral therapy, adults with HIV and TB 
infection have a 7%–10% risk of developing TB each year.19,20 
Infants (children ,12 months) with HIV are twenty times 
as likely to develop TB as children without HIV.68 Children 
who are malnourished or who have other forms of immune 
deficiency have been shown to be more vulnerable as well.69 
Another significant factor in determining the likelihood of 
progression is how recently a child was infected. If a child is 
going to develop disease, the majority will progress within 
12 months of infection.50,70 Therefore, children infected 
more than 1 year ago are less likely to progress than children 
recently infected.
BCG has been shown in many studies to protect children 
from the development of TB disease, with the effect most 
marked for young children and against the most severe, extra-
pulmonary forms of TB.71–73 However, the protective effect 
of BCG seems to vary depending on the location that it is 
used; it has been suggested that its efficacy wanes towards 
the equator. This may be due to either masking or interaction 
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with non-tuberculous mycobacteria, which are more common 
in tropical locations.74 Both mycobacterial and host genotypes 
also seem to influence the risk of progression. Beijing strain 
has been shown in some studies to be associated with dis-
seminated disease in adults.42,75,76 However, this pattern has 
not been demonstrated in children.77 Certain host genes are 
more common in people who develop TB disease than those 
who do not, as described above.62,63
Regional epidemiology  
of pediatric tuberculosis
Donald has suggested that one of the main factors con-
tributing to the importance of childhood TB in developing 
communities is the shape of the population pyramid; in 
many developing countries, between 40% and 50% of the 
population are under the age of 15 years.8,9 Figure 2 shows 
the age- and gender-related incidence in a hypothetical high-
incidence community and contrasts this with a low-incidence 
community. In low-incidence communities, TB becomes 
confined to the older generations with fewer children and less 
frequent exposure to adults with pulmonary disease. In high-
incidence communities, in addition to more children, there 
is also increased exposure to adults with pulmonary disease 
due to sociodemographic factors such as overcrowding, etc. 
The split between high- and low-incidence communities may 
therefore be artificial and sometimes overlapping populations 
may coexist within the same geographical regions. This is 
frequently seen in Western European cities, where TB preva-
lence in some administrative regions can be greater than ten 
times that of the region next to them.78
Another consequence of varying population structures, 
again described by Donald,79 is that in high prevalence 
regions, not only are more children exposed (due to the higher 
force of infection and a larger proportion of children in the 
community), but children are also exposed at a younger age 
and consequently are more likely to progress to disease. He 
suggested that a relationship exists between the prevalence of 
TB in a community and the proportion of TB that is found in 
children. With incidence rates of 10/100,000, the proportion 
of cases found in children is less than 10%, but this increases 
to 40% where the incidence is 1,000/100,000.
European region
TB case notifications in Europe make up less than 10% of 
worldwide notifications to the WHO.3 Case notifications 
reveal disparities between countries in the European Union 
(EU) and the non-EU countries, particularly those in Eastern 
Europe, comprising mostly states of the former Soviet Union. 
Table 1 shows the TB cases in children and adults in the 
European Region in 2011, broken down by EU and non-EU 
countries (adapted from the European Centre for Disease 
Prevention and Control/WHO Regional Office for Europe; 
Tuberculosis surveillance and monitoring in Europe).80
In EU Member States, pediatric case notif ications 
ranged from 0.3/100,000 to 29.6/100,000 in 2009. Overall, 
notification rates have dropped from 5.5/100,000 in 2000 to 
4.2/100,000 in 2009.81 Of all pediatric cases reported from 
2000 to 2009, only 16.9% were culture-confirmed. Further 
breakdown of TB cases in children by age group and origin 
in some EU Member States show interesting variations 
(Table 2). Romania and Spain account for the largest numbers 
on children notified from any of the EU Member States, with 
most children being native-born and only a minority being 
foreign-born. However, a three-decade review of TB in 
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Spanish children has suggested that the proportion of cases 
diagnosed in immigrant children has risen from 2% to 46%.82 
In France and the UK, larger numbers of foreign-born chil-
dren are being seen, particularly in the 5–14 year age groups. 
This reflects the overall changes in TB epidemiology in those 
countries, with overall increases in foreign-born individuals.78 
Figure 3 demonstrates this relationship in the UK.
These data also suggest two concurrent epidemiologi-
cal patterns as described by Donald above, a low-incidence 
picture of mainly UK-born individuals skewed towards 
older age groups, presumably infected in childhood, and a 
high-incidence picture of non-UK-born young adults and 
their children, presumably infected in their countries of 
origin. Of interest are younger children in the ,5 year age 
group who are predominantly all UK-born and probably 
reflecting transmission from their non-UK-born parents. 
Epidemiological studies in children with TB in the UK would 
suggest higher rates in different ethnic groups, with rates 
in the black African ethnic group of 88/100,000 compared 
with 1.1/100,000 in the white ethnic group.83 This trend is 
particularly pronounced in urban centers in the UK such as 
London,84 Birmingham,85 and Leeds.86 Similar patterns have 
occurred in other low-prevalence countries in Europe such 
as Sweden,87 Norway,88 and Denmark.89
Pediatric data from non-EU Member States from the 
European Region are more limited. In the ECDC 2013 
report, the seven countries with the highest reported rates 
of pediatric TB in 2011 were: Kyrgyzstan 31.1/100,000, 
Georgia 28.8/100,000, Tajikistan 22.3/100,000, Uzbekistan 
21.8/100,000, Russia 16.2/100,000, Armenia 8.2/100,000, 
and Ukraine 8.0/100,000.80 In contrast to EU Member States, 
TB in these countries occurs predominantly in country-born 
children rather than foreign-born children. The emergence of 
drug-resistant TB has been an important issue in this region, 
although pediatric data are limited in national surveillance 
studies. Although it is believed that drug resistance in chil-
dren is both underestimated and underreported, the studies 
that do exist suggest that within countries, the proportion of 
pediatric cases with drug resistance is similar to the propor-
tion in adults.90
African region
After the Southeast Asian region, the African region has the 
largest numbers of children being reported, particularly from 
Sub-Saharan African countries, which make up a large pro-
portion of high-burden countries listed by the WHO.3 Many of 
the countries in this region are resource-poor, making reliable 
estimates of TB incidence difficult, especially in children. 
Lack of resources makes accurate diagnosis of TB cases more 
difficult, and in many countries, TB control programs rely 
almost exclusively on sputum microscopy for the diagnosis 
of TB, as part of WHO TB control strategies. This means 
that TB in children is both undiagnosed and underreported. 
Inadequate health information and surveillance systems in 
many countries may also contribute to inaccuracies in the 
available data. One study in the Western Cape of South 
Africa showed that of 689 cases of TB meningitis in children 
aged ,14 years, only 55% had been notified.91
Table 1 Tuberculosis cases in adults and children within the european region in 2011
Area Age 15 years Age .15 years
Number of  
cases
Percentage of  
total burden*
Incidence (number of  
cases/100,000 per year)
Number of  
cases
Percentage of  
total burden*
Incidence (number of 
cases/100,000 per year)
eU 3,190 4.4 4.0 69,084 95.5 16.1
Non-eU 8,762 2.9 11.2 210,206 69.1 66.6
Total eR 11,952 3.2 7.6 279,290 75.2 37.6
Note: *Percentages calculation based on all cases with age notified.
Abbreviations: eU, european Union; eR, european region.
Table 2 Tuberculosis cases in children (15 years old), by age group and origin in the eU in 2011
Country Native Foreign origin Unknown Total
,5 years 5–15 years ,5 years 5–15 years ,5 years 5–15 years ,5 years 5–15 years
N % N % N % N % N % N % N % N %
France 101 63.5 58 36.5 20 23 67 77 4 44.4 5 55.6 125 49 130 51
Romania 299 38 472 61.2 4 80 1 20 0 0 0 0 303 39 473 61
Spain 267 63 157 37 31 28.4 78 71.6 3 37.5 5 62.5 301 55.6 240 44.4
UK 116 44.6 144 55.4 18 12.9 121 87.1 6 42.9 8 57.1 140 33.9 273 66.1
Total eU 1,174 46.6 1,334 53.4 159 25.6 462 74.4 20 39.2 31 60.8 1,353 42.4 1,837 57.6
Abbreviation: eU, european Union.
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It is clear is that in Sub-Saharan Africa, pediatric cases 
make up a substantially higher proportion of overall TB cases 
than in other countries. Estimates based on TB prevalence sug-
gest proportions in excess of 20%.79 Although these estimates 
are open to dispute, several studies in resource-poor countries 
would agree with this figure.92,93 A study in an urban com-
munity in the Western Cape Province of South Africa (overall 
TB incidence estimated 1,149/100,000) found that 39% of the 
caseload was due to children younger than 14 years of age.94 
Furthermore, the greatest burden of TB in children appears to 
be between 12–23 months of age (1.2/100 person years) with 
the highest disease severity in this age group.95 While some 
countries have reported declines in TB incidence in children, 
others have reported dramatic increases, particularly with HIV 
coinfection, which has been estimated to occur in 8%–55% 
of newly diagnosed children with TB.95,96
A retrospective review of TB notif ications in the 
 Kilimanjaro region of Kenya showed that children con-
stituted 13% of all TB burden with average case detection 
rates of 147/100,000 for urban and 41.8/100,000 for rural 
 populations.97 Of the minority of children who were tested 
for HIV infection, 82% tested positive. Of children diagnosed 
with TB, only 24.9% had samples tested for acid fast bacilli 
using Ziehl–Neelsen staining with no other microbiological 
testing such as culture or drug susceptibility testing. Recently, 
increasing drug resistance, particularly multi-drug-resistant 
(MDR; M. tuberculosis resistant to at least rifampicin and 
isoniazid) TB, has been reported in children in Cape Town, 
South Africa but this is likely to be underreported in other 
parts of Africa without access to culture or drug resistance 
testing.98
Southeast Asian region
The Southeast Asia region has the largest number of people 
with TB in the world, with almost ten times as many case notifi-
cations in children as Europe in 2012. Although three countries 
from this region (India, Indonesia, and  Bangladesh) are in the 
top four high-burden countries listed by the WHO,3 there is 
little information on the rates of pediatric TB. Chakraborty esti-
mated that approximately 10 million children in India each year 
are at risk of being infected because of contact with a smear-
positive adult.99 Given that 5% could be expected to develop TB 
in the first 2 years following infection and another 2%–3% over 
the next 2 years, he estimated that 700,000–800,000 children 
would develop TB over the subsequent 5 years. If this was the 
case, over 80,000 children could be expected to die or suffer 
serious disability over the same 5-year period.
In Thailand, a surveillance study of four provinces and 
one national hospital for 1 year showed that only 279 (2%) of 
14,487 total cases occurred in children, with 27% having HIV 
coinfection and only one case of MDR-TB. The investigators 
propose that the infrequent diagnosis of TB in children may 
either reflect an absence of disease or underreporting due to 
difficulties in diagnosing TB in children.100
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Western Pacific region
TB case notification figures for the Western Pacific region 
from the WHO are dominated by the People’s Republic of 
China, which has the second largest number of new TB cases 
in the world.3 This is mostly due to its vast population. Apart 
from the People’s Republic of China, the Western Pacific 
region is mostly made up of small nations,  generally with 
estimated TB rates of less than 50/100,000. While the rates of 
TB have increased in the last 5 years in some countries, only 
Vietnam shows increases in rates similar to those in high-
burden Sub-Saharan African countries. In Taiwan, nationwide 
data from the National TB Registry show that the incidence 
of TB in persons ,20 years of age was 9.61/100,000 per-
son-years. However, the overall childhood TB incidence in 
Aboriginal children was 81.5/100,000 person-years which 
was almost ten times higher than for non-Aboriginal children. 
The higher rates in Aboriginal children were attributed to 
lower socioeconomic status and inherited susceptibility, in 
addition to increased risk of exposure.101
An Australian study also demonstrated clearly how 
immigration from high-prevalence countries can contribute 
significantly to the disease pattern within a low-prevalence 
population. Heath et al studied TB surveillance data for New 
South Wales between 1975 and 1995.102 During this period, the 
overall TB notification rates for the Australian-born population 
fell exponentially to around 2/100,000, while the percentage of 
notifications in those born overseas rose from 30% to 79%. In 
children ,15 years of age over this time period, rates initially 
fell, but rose again from 1992 to 1995. Notification rates were 
highest in children born overseas, while 51% of Australian-
born children with TB were from non-English speaking 
households. Similarly, a retrospective review of pediatric TB 
in New Zealand showed a resurgence of TB, predominantly 
involving non-European and immigrant groups.103
Eastern Mediterranean region
In general, TB notifications to the WHO in this region have 
remained unchanged, or have fallen since the later part of 
the last decade. This region does not contribute substantially 
to the worldwide burden of TB, and has the lowest rates of 
disease in all the WHO regions. The country with the largest 
population in the region, Pakistan, had a significant reduc-
tion in TB notifications between 1980 and 2001. However, 
case detection rates in Pakistan are very low, with the WHO 
estimating that only 10% of sputum smear-positive cases are 
being detected.3 A small study from Iran carried out between 
1999 and 2004 demonstrated low levels of drug resistance 
among M. tuberculosis isolates from children.104
American region
The total number of TB case notifications for this region has 
remained remarkably constant since 1980. This is despite 
the two countries with the greatest number of TB cases, 
Brazil and US, having both had steady decreases in case 
 notifications since 1998. Overall, TB cases in the US peaked 
in 1992, and have been steadily falling since that time. In 
2012, the Centers for Disease Control and Prevention (CDC) 
reported an estimated overall TB rate of 3.2/100,000 with a 
62% reduction in the number of TB cases reported annually 
since the peak in 1992.105,106
In the US, national rates in children ,18 years of age have 
followed a similar pattern to that seen in adult TB, falling 
from 2.1/100,000 in 1994 to 1.1/100,000 in 2007.107 TB rates 
among foreign-born children and adolescents also declined 
from 20.3/100,000 to 11.4/100,000 but remained higher than 
US-born children. Among foreign-born children with known 
month of US entry, more than 20% were diagnosed with TB 
within 3 months of entry. In a subsequent surveillance study, 
over three-quarters of pediatric patients with TB in the US 
had potential TB exposures through foreign-born parents 
or residence outside the US.108 In Canada, a school-based 
TB-screening program for recently immigrated children 
demonstrated that 21% were TST positive.109
Although there are few epidemiological studies on pedi-
atric TB in South America and patchy national reporting, 
a number of hospital-based studies have documented the 
presentation and management of children with TB. In Brazil, 
from 1999–2008, 473 children were treated at one teaching 
hospital, two-thirds with a known TB contact, the majority 
of those in the  household.110 Seventeen percent were HIV-
positive and a confirmed diagnosis was made in 31% of cases. 
In Peru, 2,392 children were described as having TB over a 
25-year period.111 Only 0.1% was found to be HIV-positive 
and the median age was 9 years. Mortality in this cohort 
was 11%, which was associated with young age and lack of 
response to tuberculin skin testing.
Global burden
There are a number of challenges to estimating the burden of 
TB in children. Most estimates use the number of reported 
pediatric cases as the starting point to estimate the burden. 
In many countries, not all children started on treatment are 
reported to the National TB Program.112 Some children are 
simply missed, and in other countries, only confirmed cases are 
reported. Further, pediatric TB can be difficult to diagnose and 
many children with TB are never started on appropriate treat-
ment. This is due to three factors. First, a confirmed diagnosis 
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Table 3 New tuberculosis case notifications in 2012, by case 
type and age disaggregation
Smear- 
positive
Smear- 
negative*
Extra- 
pulmonary
Total notifications
Countries disaggregating by age
Countries not disaggregating  
by age (percentage of total  
notifications disaggregated)
2,568,789
2,551,136
17,653  
(99%)
1,935,971
1,597,530
338,441  
(83%)
817,462
678,953
138,509  
(83%)
Number of countries that  
reported notifications  
disaggregated by age (number  
of high-burden countries)**
204 (22) 184 (14) 184 (14)
Total childhood notifications  
from countries disaggregating  
by age
46,488 163,477 91,308
Total estimated childhood  
notification among all countries
349,000
Notes: *This includes reported cases for whom smear results were unknown or not 
done; **an additional nine countries reported zero tuberculosis cases for 2012 and 
three countries had not reported data to the world Health Organization by July 2013.
Number of all TB cases reported
to WHO from countries that did
not disaggregated by age
Number of pediatric TB cases reported to
WHO from countries that disaggregated
by age
Estimate of notified
pediatric TB cases
from those countries
Estimate of all
notified pediatric TB
cases
Inflation to account
for under-reporting
(66%)
Total estimated
number of cases
Figure 4 The strategy employed by the world Health Organization to arrive at the estimate of childhood tuberculosis cases.
Abbreviations: TB, tuberculosis; wHO, world Health Organization.
can be challenging due to difficulties in the collection of 
clinical samples, as well as low rates of culture-confirmation 
in those for whom samples are collected.113 Second, a clinical 
diagnosis can also be challenging, as unlike adults where the 
signs and symptoms of TB are relatively sensitive and specific, 
TB in children can be non-specific,114 and in many parts of the 
world where TB prevalence is high, other diseases exist with 
overlapping features. Finally, in remote and rural areas of the 
world, it is likely that many children are never brought to the 
attention of medical services once symptomatic.
The WHO estimated that there were 530,000 TB cases in 
children in 2012 and 74,000 deaths among children who were 
HIV-negative.115 The global number of TB case  notifications 
among children (aged ,15 years) was estimated at 349,000 
in 2012 (Table 3). This includes cases reported from children 
and an estimate of the number of cases among children in 
countries that did not report notifications disaggregated 
by age. To estimate TB incidence among children, it was 
assumed that the case detection rate for all ages at the global 
level in 2012 (best estimate 66%, range 64%–69%) was the 
same for adults and children (Figure 4). On this basis, TB 
incidence among children was estimated to be 530,000 (range 
510,000–550,000) in 2012, equivalent to about 6% of the 
total number of 8.6 million incident cases. Limitations of this 
methods include: 1) the assumption that the case detection 
rate is the same for adults and children, in the absence of 
any data on levels of underreporting of the diagnosed cases 
for children and adults separately; 2) the assumption that 
reported cases were true cases of TB; and 3) the proportion 
of cases among children may be different in countries for 
which disaggregated data were not available. The regional 
breakdown of new TB case notifications in 2012, by age, 
sex, and WHO region is shown in Table 4 (adapted from the 
Global Tuberculosis Report 2013).3
Infection and Drug Resistance 2014:7submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
162
Seddon and Shingadia
Almost all (96%) of the notifications of new smear-
positive cases were disaggregated by age, of which 2% or 
42,127 cases were in children aged ,15 years. Reporting of 
cases disaggregated by age and sex was much less complete 
for smear-negative pulmonary and extrapulmonary cases. 
When the available data for all new cases were combined, 
6% or 292,295 cases were among children ,15 years. The 
Southeast Asian region accounted for the largest number of 
new cases, with a total of 119,186 cases, followed by the 
African region with 97,629 cases.
An alternative attempt to estimate the burden of childhood 
TB was carried out using 2000 data.116,117 It used, as a starting 
point, estimates of smear-positive TB for different age groups, 
in each of the 22 high-burden countries. These were then 
combined with estimates of the proportion of cases expected 
to be smear-positive for each age group to calculate the total 
number of cases in each age group. This technique produced 
an estimate for the 22 high-burden countries of 659,397 
pediatric (,15 years) cases or 9.6% of the burden in those 
countries. When extrapolated to all countries, the approach 
yielded an estimate of 884,019 pediatric cases globally.
Conclusion
It is important to understand both the natural history and 
epidemiology of childhood TB in order to assess which 
children are the most vulnerable and also to begin to 
understand the burden on a regional, national, or global 
level. It is also important as it allows appropriate target-
ing of health resources and for purposes of advocacy. 
Currently, estimates of burden are somewhat incomplete 
due to imperfect diagnosis, recording, and reporting, as 
well as by limitations to the methodology used to make 
Table 4 The regional breakdown of new tuberculosis case notifications in 2011, by age and World Health Organization region
0–14 years 15–44 years 45–64 years $65 years % Aged ,15 years Male/female 
ratio
Afghanistan 669 8,574 3,319 1,227 5 0.51
Bangladesh 932 53,585 30,877 13,554 ,1 1.9
Brazil 692 25,270 11,080 3,211 2 2.2
Cambodia 73 6,810 6,412 2,581 ,1 1.2
People’s Republic of China 1,378 173,523 128,585 73,519 ,1 2.6
DR Congo 3,379 47,529 17,207 3,206 5 1.2
ethiopia 3,830 38,518 6,272 1,074 8 1.2
India 12,985 388,447 187,705 53,174 2 2.2
Indonesia 1,714 115,631 67,378 13,074 ,1 1.5
Kenya 985 29,884 5,207 1,009 3 1.6
Mozambique – –
Myanmar 307 23,902 14,198 3,907 ,1 1.9
Nigeria 1,107 34,559 9,604 2,167 2 1.6
Pakistan 3,895 64,309 27,495 10,034 4 1.1
Philippines 953 51,919 31,069 6,935 1 2.4
Russian Federation 51 18,066 9,477 1,597 ,1 2.7
South Africa 3,404 94,427 27,552 4,387 3 1.2
Thailand 114 14,980 11,862 6,213 ,1 2.4
Uganda 695 18,486 4,842 917 3 1.8
UR Tanzania 411 17,149 5,047 1,508 2 1.8
vietnam 95 23,404 18,271 8,949 ,1 3.0
Zimbabwe 326 9,953 1,879 438 3 1.2
High-burden countries 37,995 1,258,925 625,338 212,681 2 1.9
Africa 19,183 427,731 114,303 23,574 3 1.4
America 2,337 62,127 27,495 11,311 2 1.8
eastern Mediterranean 5,763 105,833 42,736 16,303 3 1.2
europe 391 46,807 24,197 6,962 ,1 2.3
Southeast Asia 17,144 626,659 329,687 93,857 2 2.0
Western Pacific 2,880 272,434 196,490 104,444 ,1 2.4
Global 47,698 1,541,591 734,908 256,451 2 1.9
Notes: Reproduced with permission from the world Health Organization. Global Tuberculosis Report. Geneva: world Health Organization; 2012: wHO/HTM/TB/2012.6. 
Available from: http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502_eng.pdf.3 Copyright © 2012, world Health Organization.
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estimates from the number of cases reported. However, 
the tide appears to be turning and it is hoped that the TB 
epidemic in children will be more completely understood 
in the coming years.
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